Read More Pharma Industry News Avacta Group advances Phase 1 trial of oncology drug candidate AVA6000 Avacta Group plc (AIM: AVCT), a prominent life sciences company, has achieved a significant milestone in its Phase… byPallavi MadhirajuMay 24, 2024